Treatment of mild persistent asthma.
There are several treatment options available for patients who have mild persistent asthma. After being shown a typical case study and three possible treatment options, three respiratory specialists each selected a different option. The options were: using a combination beclometasone/albuterol inhaler on an as-needed basis; daily treatment with an oral leukotriene receptor antagonist together with asneeded use of a short-acting beta2-agonist (SABA) inhaler; and using a combination inhaled corticosteroid/long-acting beta2-agonist inhaler once-daily together with as-needed SABA. The evidence for each option is reviewed in the light of recent research.
Kaplan
Alan
A
Chair, Family Physician Airways Group of Canada.
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D000328:Adult; D000420:Albuterol / Q000008:administration & dosage; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001507:Beclomethasone / Q000008:administration & dosage; D005260:Female; D006801:Humans; D020024:Leukotriene Antagonists / Q000008:administration & dosage; D012720:Severity of Illness Index
D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D020024:Leukotriene Antagonists; D001507:Beclomethasone; D000420:Albuterol